High 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer
11KT is a key component of the hormonal profile predictive of earlier onset of CRPC. Enhancing our understanding of the specific role of 11KT in the progression to CRPC could help optimize hormonal therapy for castration-sensitive patients with PCa and CRPC.
Authors
- Cylia Dahmani
- David Simonyan (ORCID: https://orcid.org/0000-0001-8826-7428)
- Éric Lévesque (ORCID: https://orcid.org/0000-0001-5986-3458)
- Simone Chevalier (ORCID: https://orcid.org/0000-0001-7009-0003)
- Patrick Caron (ORCID: https://orcid.org/0000-0002-0524-7892)
- Fred Saad (ORCID: https://orcid.org/0000-0003-2986-5617)
- Michel Carmel
- Chantal Guillemette (ORCID: https://orcid.org/0000-0002-1113-1212)
- Louis Lacombe (ORCID: https://orcid.org/0000-0003-4811-0308)
- Armen Garo Aprikian
Institutions
- Université de Sherbrooke (CA)
- McGill University Health Centre (CA)
- Centre hospitalier universitaire de Québec (CA)
- Centre hospitalier de l'Université Laval (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
Publication Details
- Journal
- The Journal of Urology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1097/ju.0000000000004333
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- McGill University
- Movember Foundation
- McGill University Health Centre
- Prostate Cancer Canada
- Canadian Institutes of Health Research